Log in or create an account for full access to this data.
Create a free account or log in to use this tool.
Create a free account or log in to explore DrugBank data.
DB17037ExperimentalSmall molecule
NNC-55-0396 is a T-type Ca(2+) channel inhibitor.
- Mechanism
- Curator reviewed
Pharmacologically active on Voltage-dependent T-type calcium channel
- Formula / weight
- C30H38FN3O2 · 491.651 g/mol (avg)
- Also known as
- Cyclopropanecarboxylic acid, (1s,2s)-2-(2-((3-(1h-benzimidazol-2-yl)propyl)methylamino)ethyl)-6-fluoro-1,2,3,4-tetrahydro-1-(1-methylethyl)-2-naphthalenyl ester
- Code names
- NNC-55-0396 FREE BASE
Resolves to
Structure
InChIKey
VHHVPDKNKPNKHY-JDXGNMNLSA-NSMILESCC(C)[C@H]1C2=C(CC[C@@]1(CCN(C)CCCC1=NC3=CC=CC=C3N1)OC(=O)C1CC1)C=C(F)C=C2What you can answer from here — as of July 17, 2026
1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
Which companies are running trials of NNC-55-0396 free base, in which indications and phases, and which of those programs are still active?